Parkland Approves NeuroPace RNS Implant Contract
Trusted by teams at
Description
Parkland Health approved a three‑year, $450,000 sole‑source contract with NeuroPace, Inc. for the RNS neurostimulator implant system used to treat drug‑resistant epilepsy. The agreement runs from May 21, 2026 through May 20, 2029 and supports advanced neurosurgical capabilities in the main operating room.
Contract Details
Contract Amount
$450,000
Vendor
NEUROPACE INC
Agency
Parkland Health & Hospital System, TX
Contract Type
SUPPLIES
Document Date
May 18, 2026
Contract Term
5/21/2026 – 5/20/2029
Renewal Date
2029-05-20
Renewal Info
Initial three‑year base term from 5/21/2026 to 5/20/2029 with no out‑year options specified; any renewal would require future Board action.
More from NEUROPACE INC
More from Parkland Health & Hospital System
Dallas County Hospital District Budget, Finance & Infrastructure Committee Agenda May 2026
Parkland Health Board of Managers Agenda Packet May 2026
Dallas County Hospital District Budget, Finance & Infrastructure Committee Agenda May 2026
Parkland Health Board of Managers Agenda Packet May 2026
Dallas County Hospital District Budget, Finance & Infrastructure Committee Agenda May 2026
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.